Search Within

Narek Shaverdian

Formats
  1. Meeting Abstract (49)
  2. Journal Article (36)
  3. Editorial (5)
  4. Research Letter (4)
  5. Review (3)
  6. Correspondence (1)
Groups
  1. Radiation Oncology, Department of (98)
  2. Department of Medicine (62)
  3. Solid Tumor Oncology Division (60)
  4. Thoracic Oncology (57)
  5. Weinberg Fellows (42)
  6. Graduate Medical Education (36)

More Groups

People
  1. Daniel Gomez (77)
  2. Andreas Rimner (67)
  3. Daphna Gelblum (66)
  4. Annemarie Shepherd (62)
  5. Abraham Wu (58)
  6. Charles Simone (42)

More People

Years
  1. 2025 (2)
  2. 2024 (17)
  3. 2023 (18)
  4. 2022 (16)
  5. 2021 (21)
  6. 2020 (16)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (35)
  2. Journal of Thoracic Oncology (14)
  3. Radiotherapy and Oncology (8)
  4. Advances in Radiation Oncology (6)
  5. Journal of Clinical Oncology (5)
  6. Annals of Oncology (2)

More Publications

Publishers
  1. Elsevier Inc. (66)
  2. American Society of Clinical Oncology (7)
  3. AME Publishing Company (2)
  4. American Association for Cancer Research (2)
  5. American Medical Association (2)
  6. Oxford University Press (2)

More Publishers

Results (98)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Enhancing thoracic oncology in Armenia: Impact of the implementation of an expert-guided virtual multidisciplinary tumor board
    Meeting Abstract

    Zohrabyan, D.; Karapetyan, N.; Tamamyan, G.; Safaryan, L.; Bardakhchyan, S.; Karamyan, S.; Ghayamyan, M.; Khachatryan, M.; Danielyan, S.; Rushanyan, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • TTF-1 negativity as a biomarker of outcomes to immunotherapy, chemoimmunotherapy, and KRAS G12C inhibitors in lung adenocarcinoma
    Meeting Abstract

    Di Federico, A.; Hong, L.; Elkrief, A.; Thummalapalli, R.; Cooper, A. J.; Shaverdian, N.; Ricciuti, B.; Alessi, J. V. M.; De Giglio, A.; Pecci, F.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • 40 gray in 5 fractions for salvage reirradiation of spine lesions previously treated with stereotactic body radiotherapy
    Journal Article

    Moore, A.; Zhang, Z.; Fei, T.; Zhang, L.; Accomando, L.; Schmitt, A. M.; Higginson, D. S.; Mueller, B. A.; Zinovoy, M.; Gelblum, D. Y.; more...
    Neurosurgery (2024)

    Fulltext@MSK | Save
  • Stereotactic body radiation therapy for stage IIA to IIIA inoperable non-small cell lung cancer: A phase 1 dose-escalation trial
    Journal Article

    Rimner, A.; Gelblum, D. Y.; Wu, A. J.; Shepherd, A. F.; Mueller, B.; Zhang, S.; Cuaron, J.; Shaverdian, N.; Flynn, J.; Fiasconaro, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • An (18)F-FDG PET/CT and mean lung dose model to predict early radiation pneumonitis in stage III non-small cell lung cancer patients treated with chemoradiation and immunotherapy
    Journal Article

    Thor, M.; Lee, C.; Sun, L.; Patel, P.; Apte, A.; Grkovski, M.; Shepherd, A. F.; Gelblum, D. Y.; Wu, A. J.; Simone, C. B. 2nd; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Response letter to “Stereotactic body radiation therapy for pleural mesothelioma: Which goal, which patients”
    Correspondence

    Shin, J. Y.; Offin, M.; Simone, C. B.; Shepherd, A. F.; Wu, A. J.; Shaverdian, N.; Gelblum, D. Y.; Gomez, D. R.; Sauter, J. L.; Ginsberg, M. S.; more...
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Clinical and dosimetric risk factors associated with radiation-induced lung toxicities after multiple courses of lung stereotactic body radiation therapy
    Journal Article

    Li, X.; Yorke, E.; Jackson, A.; Yue, Y.; Simone, C. B. 2nd; Apte, A. P.; Rimner, A.; Gomez, D. R.; Shaverdian, N.; Gelblum, D. Y.; more...
    Advances in Radiation Oncology (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma
    Journal Article

    Shin, J. Y.; Offin, M.; Simone, C. B. 2nd; Zhang, Z.; Shepherd, A. F.; Wu, A. J.; Shaverdian, N.; Gelblum, D. Y.; Gomez, D. R.; Sauter, J. L.; more...
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Safety and efficacy of stereotactic body proton therapy for high-risk lung tumors
    Journal Article

    McMillan, M. T.; Shepherd, A. F.; Kang, M.; Lin, L.; Shaverdian, N.; Wu, A. J.; Gelblum, D. Y.; Ohri, N.; Lazarev, S.; Xu, L.; more...
    Journal of Radiosurgery and SBRT (2023)

    Fulltext@MSK | Save